Pandemic influenza (H1N1): Impact on lung transplant recipients and candidates

Journal of Heart and Lung Transplantation

Volumn 29, Issue 9, 2010, Pages 1034-1038

  Fox, Benjamin Daniel ^a,b   Raviv, Yael ^a   Rozengarten, Dror ^a   Rusanov, Viktoria ^a   Bakal, Ilana ^a   Kramer, Mordechai R ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

H1N1 subtype; Influenza A virus; Lung transplantation; Oorbidity; Ortality; Oseltamivir; Outcomes

Indexed keywords

OSELTAMIVIR; ANTIVIRUS AGENT;

ACUTE GRAFT REJECTION; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; INFLUENZA A (H1N1); LUNG TRANSPLANTATION; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; NOSE SECRETION; PNEUMONIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; VIRUS SHEDDING; ADOLESCENT; INFLUENZA; INFLUENZA VIRUS A H1N1; ISRAEL; LUNG DISEASE; MIDDLE AGED; PANDEMIC; PATIENT SELECTION; VIROLOGY;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHILD; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; ISRAEL; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; OSELTAMIVIR; PANDEMICS; PATIENT SELECTION;

EID: 78650457094     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2010.05.007     Document Type: Article

References (12)

1. Chan M. World now at the start of 2009 influenza pandemic. WHO 2009. http://www.who.int/mediacentre/news/statements/2009/h1n1-pandemic- phase6-20090611/en/index.html. Accessed: Jan 15, 2010.
2. Lapinsky SE. H1N1 novel influenza A in pregnant and immunocompromised patients. Crit Care Med 2010;38(4 suppl):e52-7.
3. Danziger-Isakov LA, Husain S, Mooney ML, Hannan MM. The novel 2009 H1N1 influenza virus pandemic: unique considerations for programs in cardiothoracic transplantation. J Heart Lung Transplant 2009;28:1341-7.
4. Kumar D, Morris MI, Kotton CN, et al. Guidance on novel influenza A/H1N1 in solid organ transplant recipients. Am J Transplant 2010; 10:18-25.
5. Mendelson E, Mandelboim M, Grossman Z, Ram D, Hindiyeh M. Laboratory diagnosis of influenza H1N1 2009 at the Central Virology Laboratory in Israel during the first 12 weeks of the pandemic. Harefuah 2009;148:677-81, 735.
6. Ministry of Health Israel weekly update on H1N1 influenza. http:// www.health.org.il/Download/papers/flu020110.pdf. Accessed Mar 25, 2009.
7. Mauad T, Hajjar LA, Callegari GD, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med 2010;181:72-9.
8. Kumar D, Husain S, Chen MH, et al. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients. Transplantation 2010; 27;89:1028-33.
9. Dopp JM, Wiegert NA, Moran JJ, et al. Effect of annual influenza immunization on antibody response in lung transplant patients. Prog Transplant 2009;19:153-9.
10. Hayney MS, Moran J, Wiegert NA, Burlingham WJ. Lung transplant patients' T cell responses to influenza vaccine viruses between seasons. Vaccine 2008;26:2596-600.
11. Ison MG, Sharma A, Shepard JA, Wain JC, Ginns LC. Outcome of influenza infection managed with oseltamivir in lung transplant recipients. J Heart Lung Transplant 2008;27:282-8. (Pubitemid 351375106)
12. Ling LM, Chow AL, Lye DC, et al. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin Infect Dis 2010;50:963-9.